CNS metastasis secondary to malignant-mixed Müllerian tumor: case report and review of therapeutics.

作者: Vincent Healy , Philip O'Halloran , Sorca O'Brien , Alan Beausang , John Caird

DOI: 10.2217/CNS-2017-0015

关键词:

摘要: This paper reviews CNS involvement secondary to malignant-mixed Mullerian tumor or uterine carcinosarcoma, a rare aggressive biphasic tumor. We report cerebellar metastasis with epithelial and mesenchymal components, demonstrating heterologous rhabdomyogenic chondroblastic differentiation. The patient had undergone total abdominal hysterectomy bilateral salpingo-oophorectomy for palliation of symptomatic chemotherapy-resistant node-positive disease. is rare, prognostically poor, suggestively poorer in predominantly sarcomatous metastases. Multimodal therapy indicated; solitary metastases, surgical resection stereotactic radiosurgery included, followed by whole brain radiotherapy. In unresectable radiotherapy warrant consideration up 2-3 multiple palliative steroid cranial irradiation may be considered. Combination platinum-based chemotherapy (i.e., ifosfamide-paclitaxel carboplatin-paclitaxel) indicated all stages, role both disease cure control-directed management. Targeted therapeutics have thus far not demonstrated significant clinical efficacy.

参考文章(48)
Myong Nh, Lee Sk, Kang Yd, Kim Jk, Biopsy-proven cerebellar metastasis from a malignant mixed mullerian tumor (MMMT) of the uterus: case report. European Journal of Gynaecological Oncology. ,vol. 30, pp. 196- 198 ,(2009)
Francis J. Major, John A. Blessing, Steven G. Silverberg, C. Paul Morrow, William T. Creasman, John L. Currie, Edgardo Yordan, Mark F. Brady, Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group study Cancer. ,vol. 71, pp. 1702- 1709 ,(1993) , 10.1002/CNCR.2820710440
Khadra Galaal, Esther van der Heijden, Keith Godfrey, Raj Naik, Ali Kucukmetin, Andrew Bryant, Nagindra Das, Alberto D Lopes, Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma Cochrane Database of Systematic Reviews. ,vol. 2013, ,(2013) , 10.1002/14651858.CD006812.PUB3
Chirag G Patil, Katie Pricola, J Manuel Sarmiento, Sachin K Garg, Andrew Bryant, Keith L Black, Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Cochrane Database of Systematic Reviews. ,vol. 9, pp. 0- 0 ,(2017) , 10.1002/14651858.CD006121.PUB4
Ettie Piura, Benjamin Piura, Brain Metastases from Endometrial Carcinoma International Scholarly Research Notices. ,vol. 2012, pp. 581749- 581749 ,(2012) , 10.5402/2012/581749
Kristin A. Bradley, Minesh P. Mehta, Management of brain metastases Seminars in Oncology. ,vol. 31, pp. 693- 701 ,(2004) , 10.1053/J.SEMINONCOL.2004.07.012
King Y Lam, Ui-Soon Khoo, Annie Cheung, None, Collision of endometrioid carcinoma and stromal sarcoma of the uterus: a report of two cases. International Journal of Gynecological Pathology. ,vol. 18, pp. 77- 81 ,(1999) , 10.1097/00004347-199901000-00012
Martin Nikolaus Stienen, Daniel Hinkerohe, Albrecht Harders, Sebastian Lücke, Resection of an intramedullary high cervical metastasis from a malignant mixed Muellerian tumour. Journal of Clinical Neuroscience. ,vol. 20, pp. 619- 621 ,(2013) , 10.1016/J.JOCN.2012.03.039
Martin J. Edelman, Chandra P. Belani, Mark A. Socinski, Rafat H. Ansari, Coleman K. Obasaju, Ruqin Chen, Matthew J. Monberg, Joseph Treat, Outcomes associated with brain metastases in a three-arm phase III trial of gemcitabine-containing regimens versus paclitaxel plus carboplatin for advanced non-small cell lung cancer. Journal of Thoracic Oncology. ,vol. 5, pp. 110- 116 ,(2010) , 10.1097/JTO.0B013E3181C59A3A
Halla S. Nimeiri, Amit M. Oza, Robert J. Morgan, Dezheng Huo, Laurie Elit, James A. Knost, James L. Wade, Edem Agamah, Everett E. Vokes, Gini F. Fleming, A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: A trial of the Chicago, PMH, and California Phase II Consortia Gynecologic Oncology. ,vol. 117, pp. 37- 40 ,(2010) , 10.1016/J.YGYNO.2010.01.013